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In order to develop a novel, safe and immunogenic fowl typhoid (FT) vaccine candidate, a Salmonella Gallinarum
ghost with controlled expression of the bacteriophage PhiX174 lysis gene E was constructed using pMMP99
plasmid in this study. The formation of the Salmonella Gallinarum ghost with tunnel formation and loss of
cytoplasmic contents was observed by scanning electron microscopy and transmission electron microscopy. No
viable cells were detectable 24 h after the induction of gene E expression by an increase in temperature from 37 °C
to 42 °C. The safety and protective efficacy of the Salmonella Gallinarum ghost vaccine was tested in chickens that
were divided into four groups: group A (non-immunized control), group B (orally immunized), group C
(subcutaneously immunized) and group D (intramuscularly immunized). The birds were immunized at day 7 of age.
None of the immunized animals showed any adverse reactions such as abnormal behavior, mortality, or signs of FT
such as anorexia, depression, or diarrhea. These birds were subsequently challenged with a virulent Salmonella
Gallinarum strain at 3 weeks post-immunization (wpi). Significant protection against the virulent challenge was
observed in all immunized groups based on mortality and post-mortem lesions compared to the non-immunized
control group. In addition, immunization with the Salmonella Gallinarum ghosts induced significantly high systemic
IgG response in all immunized groups. Among the groups, orally-vaccinated group B showed significantly higher
levels of secreted IgA. A potent antigen-specific lymphocyte activation response along with significantly increased
percentages of CD4+ and CD8+ T lymphocytes found in all immunized groups clearly indicate the induction of
cellular immune responses. Overall, these findings suggest that the newly constructed Salmonella Gallinarum ghost
appears to be a safe, highly immunogenic, and efficient non-living bacterial vaccine candidate that protects
against FT.Introduction
The Gram-negative bacterium, Salmonella enterica sero-
var Gallinarum (Salmonella Gallinarum), is one of the
major intracellular bacterial pathogens that causes fowl
typhoid (FT), a septicemic disease of domestic birds, pri-
marily chickens [1,2]. Salmonella Gallinarum infection is
specifically limited to avian species and rarely causes
food poisoning in humans [2]. FT is manifested by acute
mortality, usually 60–70%, and severe inflammation in-
cluding hepatitis, splenitis, typhlitis, and omphalitis,* Correspondence: johnhlee@jbnu.ac.kr
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distribution, and reproduction in any mediumwhich results in significant economic losses to the
poultry industry worldwide. The eradication of this dis-
ease is extremely problematic in countries where the
ambient temperature necessitates the use of open-sided
housing [3-5].
There have been several attempts to prevent FT by
vaccination [5-9]. The rough mutant strain Salmonella
Gallinarum 9R developed 50 years ago has been exam-
ined due to its protective efficacy against FT [9]. How-
ever, the use of live Salmonella Gallinarum 9R vaccine is
limited to layer breeds older than 6-weeks and is asso-
ciated with several disadvantages such as insufficient
protection, low growth rate [6], and residual virulencetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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[10]. Other trials with live attenuated Salmonella vac-
cines have shown successful induction of both mucosal
and systemic immunity [11,12]. However, the major
drawbacks with using these live vaccines are the safety
of the animals and environmental contamination via
fecal shedding. The alternative for these live vaccines
could be the use of subunit or inactivated vaccines. The
administration of a subunit vaccine along with an adju-
vant has been shown to offer better protection than an
experimental live vaccine [6]. However, common inacti-
vation methods such as the use of formalin or heat for
producing conventional inactivated vaccines often result
in reduced or altered antigenic characteristics of the vac-
cines, and could be responsible for inducing impaired
immune responses [13,14]. Therefore, a vaccine that can
be safely administered to chickens (especially at a young
age) to obtain desired immune responses and offer suffi-
cient protection from FT is needed.
The bacterial ghost (BG) represents an innovative ap-
proach in non-living vaccine technology for producing
safe and potent vaccines against a wide variety of infec-
tious diseases [15-18]. Bacterial ghosts are empty cell
envelopes that are produced by the controlled expres-
sion of the phiX174 lysis gene E in Gram-negative bac-
teria. Expression of the lysis gene E leads to the
formation of trans-membrane tunnels through which
the cytoplasm containing the bacterial genome [15,18]
and plasmids is expelled due to high osmotic pressure
inside the cell. The resulting bacterial ghosts are believed
to retain all functional, morphological, and immuno-
genic determinants on the cell surface, and are able to
induce cellular and humoral immune responses, result-
ing in effective immunoprotection [19]. Following ghost
formation, even highly sensitive and fragile structures
such as pili are preserved [20,21]. Since lysis tunnel for-
mation is restricted to only a small part of the total cell
surface and lysis by gene E does not chemically or phys-
ically disrupt bacterial surface structures, the resulting
ghosts share the functional and antigenic determinants
of the envelope with their living counterparts; thus, theTable 1 Bacterial strains and plasmids used in this study
Strains/plasmid D
E. coli
Top 10 F-mcrA (mrr-hsdRMS-mcrBC) F80 lacZ M15 lacX74
Salmonella Gallinarum
JOL394 Salmonella Gallinarum, isolated from chicken
JOL 1277 Salmonella Gallinarum JOL394 containing pMMP99
Plasmids
T-vector Cloning vector; pUCori AmpR
pMMP99 A derivative of T-easy carrying ghost cassetteghosts can elicit prolonged and profound immunity
[22-25]. In this study we constructed Salmonella Galli-
narum ghosts using a plasmid containing the phiX174
lysis gene E. These Salmonella Gallinarum ghosts appear
to be a safe vaccine candidate that significantly induces
cellular and humoral immune responses, and confers
significant protection against virulent Salmonella Galli-
narum infection in chickens.
Materials and methods
Ghost plasmid construction and growth conditions
Bacterial strains and plasmids used in this study are
listed in Table 1. Plasmid pHCE GAPDH ghost 37SDM
carrying the parent ghost cassette was constructed as
previously described [26]. PCR amplification of the ghost
cassette was performed using pHCE GAPDH ghost
37SDM as a template and the primers ghost-F-XbaI (5′-
TCTAGAGACCAGAACACCTTGCCGATC-3′) and ghost-
R-XbaI (5′- TCTAGAACATTACATCACTCCTTCCG-3′).
The amplified DNA segment was cloned into a T-easy
vector (Promega, Madison, WI, USA), and designated as
pMMP99. JOL394, a wild-type Salmonella Gallinarum
(Salmonella Gallinarum) strain, was used for the con-
struction of the ghost vaccine strain. The plasmid
pMMP99 was used to transform JOL394 cells on LB agar
containing 50 μg/mL of ampicillin; the resulting strain
was denoted as JOL1277. All strains were preserved in
LB broth with 20% glycerol and stored at −80 °C until
use. Phosphate buffered saline (PBS, pH= 7.4) was used
to resuspend the Salmonella Gallinarum ghost vaccine as
well as the challenge strain.
Production of the salmonella gallinarum ghosts
JOL1277 cells harboring pMMP99 were inoculated into
20 mL of LB broth containing 50 μg/mL of ampicillin.
The cultures were incubated at 37 °C with slow agitation
until the optical density (OD) at 600 nm was 0.3–0.4. To
induce gene E-mediated lysis, the temperature was
increased to 42 °C. After increasing the temperature
from 37 to 42 °C, lysis was monitored by performing vi-
able cell counts at different time points (6, 12, 18 andescription References
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harvested by centrifugation (4000 × g for 10 min),
washed three times with sterile PBS, suspended in PBS,
and stored at-20 °C.
Scanning electron microscopy (SEM) and transmission
electron microscopy (TEM)
The morphological features of the Salmonella Galli-
narum ghosts (JOL1277) and a Salmonella Gallinarum
wild-type strain (JOL394) as a control were examined by
scanning electron microscopy (SEM) and transmission
electron microscopy (TEM) as previously described with
minor modifications [27,28]. Briefly, cell materials were
harvested by centrifugation (4000 × g for 10 min) and
fixed in 2.5% glutaraldehyde in PBS (pH 7.4). This was
followed by post-fixation in 1% aqueous osmium tetrox-
ide and then serial dehydration in acetone. Samples were
critical point dried and coated with a gold-palladium
alloy for subsequent observation by SEM (JSM-5200,
JEOL, Japan). To prepare negatively-stained TEM speci-
mens, a drop of the Salmonella Gallinarum ghost sus-
pension was placed on carbon-coated copper grids. The
grids were allowed to stand for 2 min to permit films to
form on the grids, the extra solution was removed using
blotting paper, and the grids were dried. TEM was per-
formed with a HITACHI-JP/H7600 microscope (Hitachi
Science Systems, Japan) operated at an accelerating volt-
age of 100 kV.
Evaluating the safety dose of the salmonella gallinarum
ghost vaccine candidate in chickens
All animal experiments described in this study were con-
ducted with approval (CBU 2011–0017) from the Chon-
buk National University Animal Ethics Committee in
accordance with the guidelines of the Korean Council
on Animal Care. One-day old female Brown Nick chick-
ens were used for all the experiments, and provided with
water and antibiotic-free feed ad libitum. To determine
the safety and appropriate dose for inoculation of a
ghost vaccine, a preliminary experiment was carried out
in chickens. The chickens divided into three groups
(n= 15 per group), were inoculated via oral route using
107, 108 and 109 bacterial ghosts at day 7 of age. The
control group was inoculated orally with PBS. The gen-
eral condition of the birds was evaluated daily until
3 weeks post-immunization (wpi). Mortality and the de-
velopment of clinical symptoms of FT such as anorexia,
depression, and greenish-tinted diarrhea were moni-
tored. Loss of appetite, feed residue, and low responsive-
ness to external stimuli were monitored to identify
anorexia and depression. The birds were subsequently
challenged at 21 days post-immunization with 100 μL of
a suspension containing 1 × 106 CFU of a wild-type Sal-
monella Gallinarum JOL394 strain and assessed formortality. Before the actual vaccination-challenge experi-
ment, a small experiment was carried out to monitor the
adverse effects of the intramuscular and subcutaneous
inoculation with Salmonella Gallinarum ghost vaccine in
chickens. The birds (n= 10/route) were inoculated with
PBS containing 108 Salmonella Gallinarum ghosts via
the intramuscular and subcutaneous route. The control
birds (n= 10/route) received only PBS. None of the birds
exhibited any adverse inflammatory reactions when
inoculated with Salmonella Gallinarum ghost vaccine or
PBS by intramuscular and subcutaneous routes.
Salmonella gallinarum ghost vaccine protection against
bacterial challenge
Based on the previous safety dose evaluation data, Sal-
monella Gallinarum ghosts were inoculated at 1010 in-
oculation dose by oral route and 108 Salmonella
Gallinarum ghosts (100 times less than the oral dose) for
intramuscular or subcutaneous inoculation. All groups
of chickens were immunized with the bacterial ghosts at
the 7th day of age. In group B, the birds were orally
inoculated with the Salmonella Gallinarum ghosts at a
concentration of 1 × 1010 cells/0.1 mL/chicken. In group
C, the chickens subcutaneously received the ghosts in
0.1 mL of a suspension containing 1 × 108 cells/chicken.
Group D birds were injected intramuscularly with
0.1 mL of the Salmonella Gallinarum ghost suspension
containing 1 × 108 cells/chicken. The control group A
was kept as non-immunized control. Post immunization,
the birds were monitored for mortality and any detri-
mental effects induced by Salmonella Gallinarum ghost
vaccine as described above. The birds in all groups were
challenged with 100 μL of a suspension containing
1 × 106 CFU of a wild-type Salmonella Gallinarum
JOL394 strain on day 21 post-immunization. The mor-
tality rate was assessed daily for 14 days after the chal-
lenge. All birds were then sacrificed and examined for
macroscopic lesions. Lesion scores were determined and
recorded using a system similar to the one previously
described [29-31] with modifications. Each gross hepatic
and splenic lesion was assigned a score of 0, 1, 2, or 3.
Hepatic and splenic lesion scores were considered mod-
erate or severe depending on organ enlargement and the
presence of white necrotic foci. A score of 0 indicated
no lesions whereas a score of 1 was assigned to indicate
hepatomegaly or splenomegaly. The presence of over 10
white necrotic foci on the liver and spleen was scored as
2, and the presence of more than 10 white foci along
with the liver and spleen enlargement was scored as 3.
The lesion score for dead birds in all groups was 3. A
mean lesion score per group was determined, and differ-
ences among the groups were statistically analyzed.
Upon post-mortem examination, the presence of the
challenge strain in internal organs of birds with FT
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of the liver and spleen was directly inoculated on BGA
and incubated overnight at 37 °C. Thereafter, the organs
were minced and suspended in buffered peptone water
(Becton, Dickinson and Company), and the homogenate
was incubated overnight at 37 °C with continuous shak-
ing, followed by culture in Rappaport- Vassiliadis R10
broth (Becton, Dickinson and Company) for 48 h at 42 °
C. A loop of the enrichment broth was streaked onto
BGA and the Salmonella- type colonies were examined
after incubation at 37 °C for 24 h.
Collection of plasma and samples for measuring intestinal
secretory IgA (sIgA)
Plasma and intestinal washes were collected from five
birds in each group to evaluate the immune responses at
each week post-immunization. The plasma samples were
obtained by centrifugation of the peripheral blood. The
intestinal wash samples were collected as previously
described with some modifications [32]. Briefly, the birds
were orally administered a lavage solution [(6 mM poly-
ethylene glycol (PEG; 3350 molecular weight), 40 mM
Na2SO4, 20 mM NaHCO3, 10 mM KCl; and 25 mM
NaCl, pH= 7.6)] at 5 mL/kg of body weight. The birds
were individually placed in clean empty buckets and
monitored for 30 min until they began to excrete feces.
At this time, a sterile solution of 5% pilocarpine (Sigma,
St. Louis, MO, USA) in water was injected intramuscu-
larly at 50 mg/kg body weight. Administration of pilo-
carpine was followed by immediate and intermittent
excretion of intestinal fluid for 30 min. After collection,
the intestinal fluid was vortexed and centrifuged at
700 × g for 10 min. One mL of the supernatant was
saved and added to 10 μL of a 100 mM phenylmethane-
sulfonyl fluoride (PMSF; Sigma,) solution, 10 μL of 1%
(w/v) sodium azide, and 10 μL of 5% (w/v) bovine serum
albumin. The samples were stored at −20 °C until use.
Humoral immune response evaluation
An indirect enzyme-linked immunosorbant assay
(ELISA) was performed with an outer membrane protein
(OMP) extracted from the JOL394 Salmonella Galli-
narum as described before [30]. The presence of plasma
IgG and intestinal sIgA against the OMP was identified
using a chicken IgG and IgA ELISA quantitation kit
(Bethyl Laboratories, Montgomery, TX, USA). The wells
of a MicrolonW ELISA plate (Greiner Bio-One GmbH,
Frickenhausen, Germany) were coated with 100 μL of
OMP at a concentration of 0.2 mg/mL. Wells were incu-
bated with a 1:250 dilution of plasma for 1 h, followed
by incubation with a 1:100 000 dilution of horseradish
peroxidase (HRP)-conjugated goat anti-chicken IgG
(Bethyl Laboratories, Montgomery, TX, USA) for 1 h.
The bound HRP activity was measured using o-phenylmethylsulfonyl fluoride (Sigma-Aldrich). The op-
tical density at 492 nm was measured with an ELISA
reader after the reaction was stopped with 50 μL of 3 M
sulfuric acid. The sIgA concentrations were quantified
using procedures similar to the ones that were used to
measure plasma IgG levels (except that the intestinal
wash samples were diluted 1:100).
Cellular immune response evaluation
Antigen-specific cell activation of peripheral blood
mononuclear cells
A lymphocyte activation assay was carried out as previ-
ously described to evaluate cell-mediated immunity in
the immunized groups [33]. Soluble antigen was pre-
pared from the Salmonella Gallinarum wild-type strain
JOL394 as previously described [31]. Briefly, the bacterial
cell suspension was sonicated for 2 min, and centrifuged
at 5000 × g for 60 min at 4 °C. Supernatant containing
the sonicated bacterial cell protein suspension (sbcp)
was used as the soluble antigen. Peripheral blood mono-
nuclear cells (PBMC) were separated from five chickens
randomly selected from each group using a gentle swirl
technique [34] on day 21 post-immunization. Trypan
blue dye exclusion testing was done to determine cell
viability. A 100 μL suspension of viable mononuclear
cells containing 1 × 105 cells/mL added to RPMI-1640
medium supplemented with 10% fetal calf serum,
2 mM L-glutamine, 50 U/mL penicillin, 50 μg/mL
streptomycin, and 2 μg/mL fungizone. The suspension
was incubated in triplicate in the wells of 96-well tissue
culture plates with 50 μL of medium alone (negative
control) or medium containing 4 μg/mL of sbcp at 40 °C
in a humidified 5% CO2 atmosphere for 72 h. The
10 μg/mL Concanavalin A (ConA, Sigma, St. Louis, MO,
USA) stimulated lymphocyte cells were kept as a positive
control and activity of the stimulated cell suspension
was measured. Activation of stimulated lymphocytes was
measured using adenosine triphosphate (ATP) biolumin-
escence as a cell viability marker with a ViaLightW Plus
Kit (Lonza, Rockland, ME, USA), which estimated mito-
chondrial activity [35]. The emitted light intensity was
measured using a TriStarLB941 luminometer (Berthold
Technologies GmbH and Co., Bad Wildbad, Germany)
with an integrated program of 1 s duration. The values
for each group are expressed as relative luminescence
units (RLU).
Flow cytometry analysis of CD3+, CD4+ and CD8+ subsets
T cell markers such as CD3+, CD4+, and CD8+ were
examined by collecting peripheral blood mononuclear
cells (PBMC) from all the groups on day 7 post-
immunization [36]. The cell suspensions were prepared
at a concentration of 1 × 106 cells/mL in cold PBS. The
cells were washed three times in PBS and then incubated
Table 2 Viable cell count after induction of gene E
mediated lysis
Incubation hoursa OD600 CFU
b
0 0.320 2.5 × 109
6 0.188 1.8 × 104
12 0.178 4 × 103
18 0.150 1 × 103
24 0.167 0
a The cultures were collected at different time intervals such as 0, 6, 12, 18
and 24 h after the induction of lysis.
b The viable cell count was measured as colony forming units (CFU)/mL.
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cyanate (FITC)-labeled anti-CD3, biotin (BIOT)-labeled
anti-CD4 and phycoerythrin (PE)-labeled anti-CD8a
(SouthernBiotech, Birmingham, AL, USA) monoclonal
antibodies in the dark at 4 °C for 30 min. After washing
three times with cold PBS, the cells were incubated with
0.1 mL of appropriately diluted allophycocyanin (APC)-
labeled streptavidin (SouthernBiotech, Birmingham,
USA) monoclonal antibody in the dark at 4 °C for
30 min. After incubation, all samples were washed three
times with cold PBS, resuspended in 0.5 mL of PBS, and
analyzed with a flow cytometer (BD Biosciences, NJ,
USA). FACS analysis of 10 000 events was performed
using CellQuest software (BD Biosciences).
Statistical analysis
All data are expressed as the mean± standard deviation
(SD) unless otherwise specified. Analyses were per-
formed with SPSS version 16.0 software (SPSS, Chicago,
IL, USA). A non-parametric chi-square test was used to
analyze significant differences in mortality and gross le-
sion scores. A one way ANOVA with post hoc Bonfer-
roni adjustments was used to analyze statistical
differences in immune responses between the immu-
nized groups and unimmunized control group. Differ-
ences were considered to be statistically significant when
the P-values were ≤ 0.05 or 0.01.
Results
Construction of the ghost cassette and lysis of salmonella
gallinarum bacterial ghosts
The ghost cassette contained the cI PR promoter from
bacteriophage lambda and E gene from phiX174 fused at
transcriptional and translational levels. A new ghost cas-
sette designated as ghost SDM37 was constructed as
described in a previous study [26]. The SDM37 ghost
system was prepared by introducing a mutation in an
operator region encoding the R gene. The point-mutated
site in ghost SDM37 was located at OR2 which consisted
of 17 nucleotides (nts). Among the 17 nts, the ninth nu-
cleotide, C, was replaced with T in ghost SDM37. Be-
cause of this, the strain carrying the SDM37 ghost
system could grow at temperatures lower than 37 °C but
were unable to grow at temperatures higher than 37 °C
due to the induction of lysis.
A plasmid (pMMP99) containing the ghost cassette
was used to transform a wild-type Salmonella Galli-
narum strain, JOL394. Production of Salmonella Galli-
narum ghosts in a 25 mL liquid culture of randomly
selected clones was accomplished by increasing the
temperature up to 42 °C to activate gene E-mediated
lysis. The OD of the transformed Salmonella Gallinarum
culture decreased during 6 h after induction of gene E
expression due to cell lysis and remained constant forthe next 24 h until the bacterial ghosts were harvested
(Table 2). Cell viability also decreased after lysis induc-
tion until the time of ghost harvesting (Table 2). The
concentration of viable bacteria, 6 h after lysis induction,
decreased 105-fold orders of magnitude (Table 2). Lysis
was completed 24 h after the initiation at which time no
viable cells were detected.
Formation of the Salmonella Gallinarum ghosts was
examined by SEM and TEM. Electron microscopic
analysis revealed the formation of lysis pores in the
Salmonella Gallinarum ghosts (indicated by arrowheads
in Figure 1a). Pores resulting from gene E tunnel forma-
tion could be seen either in the pole region or central
division region (Figure 1a). TEM examination showed
that the Salmonella Gallinarum ghost cells were empty
due to the loss of cytoplasmic material and had col-
lapsed cell envelopes compared to the wild-type cells
(Figure 1b).
Safety of the ghost vaccine candidate in chickens
Seven-day-old chickens were inoculated with the Sal-
monella Gallinarum ghost strain. To evaluate the safety
of the vaccine, parameters including clinical symptoms
and mortality were measured post-immunization. No
vaccination associated mortality was observed in any of
the immunized groups. Furthermore, the birds remained
healthy without any symptoms of anorexia, diarrhea, or
depression for 3 weeks after inoculation with the ghost
strain.
Humoral immune responses
Humoral immune responses specific for the OMP anti-
gen extracted from wild-type Salmonella Gallinarum
were evaluated by indirect ELISA. Systemic IgG and mu-
cosal sIgA levels were determined at every week post-
immunization by measuring specific IgG levels in plasma
and IgA concentrations in intestinal wash fluid. The
immunized birds in group B (orally immunized), group
C (subcutaneously immunized), and group D (intramus-
cularly immunized) had significantly higher plasma IgG
levels than the group A control birds (Figure 2a) every
Figure 1 Evaluation of Salmonella Gallinarum ghosts (JOL1277) and Salmonella Gallinarum (JOL394) by SEM (A and B) and TEM (C and
D). A) Salmonella Gallinarum ghosts. Arrow shows the trans-membrane lysis tunnel. B) Naive Salmonella Gallinarum examined by SEM. C) Loss of
cytoplasmic material from Salmonella Gallinarum ghosts. D) Naive Salmonella Gallinarum examined by TEM.
Chaudhari et al. Veterinary Research 2012, 43:44 Page 6 of 11
http://www.veterinaryresearch.org/content/43/1/44week post-immunization (wpi). The increases in IgG
levels at 3 wpi in the immunized groups were highly sig-
nificant compared to the non-immunized group
(Figure 2a). Sequential monitoring of intestinal sIgAFigure 2 The plasma IgG and intestinal sIgA levels in chickens agains
specific antigens were determined with the chicken IgG quantitative ELISA
quantified using the chicken IgA quantitative ELISA. Antibody levels were e
values were considered statistically significant, if p values were≤ 0.05 (*p≤
group C, immunized subcutaneously; group D, intramuscularly immunized.antibodies showed significantly increased levels in the
orally immunized group B compared to the control
group (Figure 2b). There was no significant increase in
intestinal sIgA levels in groups C or D (Figure 2b).t the outer membrane protein (OMP). A) Plasma IgG levels against
. B) The sIgA levels in intestinal wash fluids against OMP antigen were
xpressed as mean± S.D. values for each week post-immunization. The
0.05). Group A, non-immunized control; group B, orally immunized;
Figure 3 The lymphocyte stimulation responses determined at
3-week-postimmunization against the sbcp Antigen. The
stimulation index of lymphocyte sample from the chickens was
determined by the peripheral lymphocyte activation assay. The
values were considered statistically significant, if p values were≤ 0.05
(*p≤ 0.05). Group A, non-immunized control; group B, orally
immunized; group C, immunized subcutaneously; group D,
intramuscularly immunized.
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Lymphocyte activation assay
In order to evaluate the cell-mediated immune
responses, lymphocyte activation after stimulation with
soluble antigen was measured by analyzing PBMC iso-
lated from immunized and non-immunized birds at 3
wpi. The immunized birds showed significant activation
responses compared to control group A (Figure 3). The
immunized group RLU values differ significantly com-
pared to those of the control group, suggesting a dra-
matic increase of lymphocyte activation after antigen
stimulation.
Flow cytometry analysis of CD4+ and CD8+ T cells
Changes in T cell populations after immunization corre-
lated with comparable changes in serum antibody levels.
Therefore, we measured the CD4+ (T helper cells) and
CD8+ (cytotoxic T cells) T cell subpopulations among
PBMC from the immunization groups by flow cytome-
try. The relative numbers of both CD4+ and CD8+ lym-
phocytes significantly increased in all the immunized
groups (Figure 4). The immunized group had statistically(p< 0.05) higher numbers of CD3+ CD4+, and CD3+
CD8+ T cells than the non-immunized control group
(Figure 4a and b). On day 7 post-immunization, the
numbers of CD3+ CD4+ and CD3+ CD8+ T cells among
the PBMC populations of all immunized chickens were
approximately 1.5- and 2.5-fold greater than the non-
immunized control group, respectively (Figure 4).
Protective efficacy of bacterial ghosts against virulent
challenge in chickens
In the preliminary experiment for determination of
safety dose for inoculation, it was observed that the birds
immunized with 107, 108 and 109 showed 46.6, 33.5 and
26% mortality against the virulent challenge, respectively
(Table 3). Based on this, the birds were immunized with
1010 and 108 bacterial ghosts via oral and intramuscular/
subcutaneous routes, respectively and were subsequently
inoculated via oral route with the challenge strain at 3
wpi to investigate the protective efficacy of the Salmon-
ella Gallinarum ghosts against virulent challenge. The
birds were subsequently observed for mortality for
14 days post-challenge. Immunized groups B, C, and D
showed significant protection against the challenge com-
pared to the non-immunized group A (Table 4). The
immunized groups exhibited significantly lower mortal-
ity than the non-immunized control group A, which
showed 73% mortality (Table 4). The percent mortality
rates for groups B, C, and D were 14.0%, 6.6%, and 6.6%,
respectively. At day 14 post-challenge, in each group the
surviving chickens were euthanized for postmortem
examination to evaluate the protective efficacy of the
ghost vaccine. The presence of hepatic and splenic en-
largement with white necrotic spots was scored from 0
to 3 as described in “Materials and Methods”. The mean
organ lesion scores of the immunized groups were com-
pared to those of the non-immunized control group A.
All the immunized groups (B, C, and D) had significantly
lower lesion scores than those of the control group A
(Table 4). The challenge strain was not isolated from the
internal organs of any of the chicks of groups at day 14
post challenge.
Discussion
To vaccinate against FT, it is necessary that the vaccine
contains either live Salmonella vaccine strains of
reduced virulence, or inactivated organisms. In the
present study we constructed a Salmonella Gallinarum
ghost vaccine and evaluated its protective efficacy in
chickens. Bacterial ghost (BG) represents a relatively
novel concept for genetically engineered vaccine tech-
nology. However, this new ghost system has been rarely
used in poultry. BG are devoid of all cytoplasmic content
but preserve their natural outer membranes with highly
immunogenic lipopolysaccharide structures. As reported
Figure 4 Flow cytometric analysis for CD3+ CD4+ and CD3+ CD8+ T-lymphocyte populations. A) Flow cytometry scatter dot plots for CD3+,
CD4+, CD8+ T-cell populations. The plots represent events for one representative chicken from each group. The gating and the quadrants are set
according to the standard procedures of the BD-Biosciences flow cytometer B) Bar-graphs represent CD3+ CD4+ T-lymphocyte populations in
immunized and non-immunized chickens C) Bar-graphs represent CD3+ CD8+ T-lymphocyte populationin immunized and non immunized
chickens. Values are shown as Mean± S.D of 5 chickens per group and were considered statistically significant, if p values were≤ 0.05 (*p≤ 0.05).
Group A, non- immunized control; group B, orally immunized; group C, immunized subcutaneously; group D, intramuscularly immunized..
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Gallinarum ghosts as a result of lysis gene E expression
followed by formation of transmembrane tunnel struc-
tures through which the cytoplasmic contents were ex-
pelled, leaving behind the empty cell envelopes
(Figure 1). Culture solutions of Salmonella Gallinarum
ghosts produced by this method did not contain any vi-
able cells 24 h after lysis induction and no morpho-
logical changes were observed by SEM or TEM. The
onset of lysis was observed 6 h after the temperature
was increased to 42 °C with decreases in both OD600
and cell viability. Generally, strains carrying a conven-
tional ghost cassette system are able to survive at 28 °C
[37,38] whereas the ghost strain used in the present
study was grown at 37 °C, which is the optimumtemperature for normal growth of Salmonella [30], since
sub-optimal growth temperatures reduce the rate of div-
ision and thus slowdown the production process of bac-
terial ghosts. Previous studies have indicated that growth
of Salmonella at lower than 30 °C affected the lipopoly-
saccharide O-antigen size and distribution [39] and
reduced the expression of certain fimbriae [40]. These
changes in the surface structures may account for the al-
teration in antigenicity of Salmonella Gallinarum ghost.
A ghost strain, which was initially grown at 37 °C and
then exposed to 42 °C to promote the lysis, resulted in
efficient induction of immune responses [16]. Based on
this, the present study assumed that the Salmonella Gal-
linarum cells when grown under normal optimal tem-
peratures required for Salmonella growth before the
Table 3 Safety dose evaluation of the Salmonella
Gallinarum ghost vaccine candidate in chickens
Group Dosea Mortality after Challengeb (%)
Vaccinated 107 7/15 (46.6)
108 5/15 (33.5)
109 4/15 (26.6)
Control - 11/15 (73.6)
a The birds were inoculated with 1 × 107, 1 × 108 and 1 × 109 of the Salmonella
Gallinarum ghost vaccine.
b Number of dead birds upon challenge.
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genic structure efficiently to trigger the desired immune
responses.
It has been previously demonstrated that immunization
with BG vaccines offer efficient protection against highly
virulent strains in animal models [16,41]. Therefore, we
further evaluated the safety and protective efficacy of the
Salmonella Gallinarum ghosts as a vaccine candidate
against infection with a wild-type strain in chickens
immunized with Salmonella Gallinarum ghosts via either
oral, intramuscular, or subcutaneous routes. None of the
immunized groups showed any adverse reactions after
vaccination which suggests that the ghost vaccine used in
the present study could be safely administered in chickens
without any detrimental effects. Immunization with the
Salmonella Gallinarum ghosts offered significant protec-
tion against the virulent challenge based on mortality and
the development of lesions (Table 4). Animals in all the
immunized groups had significantly lower gross lesion
scores compared to the non-immunized control group.
Although no significant differences were observed amongTable 4 Mortality and gross lesion in the chickens post
challenge
Group a Challengeb
Gross lesiond Bacterial recovery
Mortality
(%)
Liver Spleen Liver Spleen
Positive No.Positive No.
A 11/15 (73)c2. 2.16 ± 1.46e**1.70 ± 1.46**0/5f 0/5
B 2/15 (14) 1.06 ± 0.96 0.66 ± 1.12 0/5 0/5
C 1/15 (6.6) 0.60 ± 0.98 0.53 ± 0.83 0/5 0/5
D 1/15 (6.6) 0.53 ± 0.89 0.53 ± 0.93 0/5 0/5
a Immunization was performed at day 7 of age with the Salmonella Gallinarum
ghost strain and the groups were designated as group A (non vaccinated),
group B (orally immunized), group C (immunized subcutaneously) and group
D (immunized intramuscularly). Fifteen birds were allocated per group.
b Challenge was performed with a wild type Salmonella Gallinarum strain
using 1 × 106 CFU after 21 days post vaccination.
c Number of dead birds upon challenge.
d Gross lesion was observed at day14 post challenge.
e Group lesion score (Mean ± SD).
f Number of positive samples after enrichment culture. All values were
considered to be significant if p≤ 0.05 or 0.01.* p< 0.05, **p< 0.01 vs. non
vaccinated group A.the immunized groups, the mortality rates and gross le-
sion scores for all the immunized groups differ signifi-
cantly compared to those of the non-immunized group.
The present study results are promising and may indicate
that the newly constructed Salmonella Gallinarum ghost
vaccine could be an effective measure to prevent FT.
However, the advantages of the presently constructed Sal-
monella Gallinarum ghost vaccine over the previously
reported live [10] or subunit vaccines [6] should be vali-
dated. This could be achieved via comparative evaluation
studies between the Salmonella Gallinarum ghost vaccine
and other live/inactivated vaccines.
Salmonella Gallinarum antigen-specific humoral and
cellular immune responses induced by vaccination have
been correlated with the protective efficacy of live vac-
cines against FT in chickens [33,42]. Unlike other inacti-
vated vaccines, BG retain all relevant antigens found on
live bacteria which can be recognized and engulfed by
dendritic cells and macrophages in immunized animals,
thereby stimulating humoral and cell-mediated immune
responses [41]. Therefore, our study further investigated
the humoral and cellular immune responses in chickens
after immunization with the Salmonella Gallinarum
ghosts. Our data indicate that immunization with the
Salmonella Gallinarum ghosts efficiently induced sys-
temic IgG responses in all immunized groups whereas
mucosal sIgA levels were significantly elevated in group
B (Figure 2a and b). The Salmonella Gallinarum ghost
vaccine induced significantly high plasma IgG levels in
chickens and the antibody levels continually increased
until 3 wpi, indicating a strong systemic immune re-
sponse in the chickens after immunization. Mucosal
sIgA levels were significantly elevated in the orally
immunized group. The stronger sIgA response was likely
to be related to the fact that the oral route of
immunization induces significantly higher mucosal
secretory IgA levels compared to the other routes [43].
Thus, our data suggest that the oral immunization with
the Salmonella Gallinarum ghosts had an additional ad-
vantage of inducing sIgA levels which serve as a first line
of defense against enteric pathogens [43] and might play
an important role in early elimination of Salmonella
Gallinarum infections. Moreover, the role of sIgA or mu-
cosal immunity in Salmonella Gallinarum clearance and
systemic FT control has not been fully elucidated [42].
The present experimental data showing sIgA induction
following oral immunization with 1010 Salmonella Galli-
narum ghosts may offer useful information about the in-
duction of intestinal sIgA antibodies although its role in
protection against the Salmonella Gallinarum clearance
in the chicken is a matter of interest. Presently, our
study indicates that immunization with an inactivated
Salmonella Gallinarum ghost vaccine via oral route is
capable of inducing mucosal immunity.
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protecting against intracellular bacterial pathogens
[16,33,44]. Salmonella Gallinarum is an intracellular
pathogen, and has been reported to invade the mono-
nuclear phagocyte system and survive in chicken macro-
phages [30]. Therefore, immunization against
Salmonella Gallinarum infection requires a vaccine that
can efficiently prevent the disease by inducing immune
responses at the cellular level. The correlation between
cellular immunity and high survival rates in chickens
after a virulent Salmonella Gallinarum challenge has
been reported, and measurements of cell-mediated im-
mune responses is an important index of protection
[30,42]. To evaluate the cellular immune responses, the
present study performed an antigen-specific lymphocyte
activation assay and, CD3+CD4+ and CD3+CD8+ T cell
populations among the PBMC of the immunized and
non-immunized groups. Our data showed that all immu-
nized groups showed significant lymphocyte activation
responses upon antigen stimulation compared to the
non-immunized groups. These lymphocyte activation
responses clearly suggest that the lymphocytes (either B
or T cells) from the immunized birds were activated
upon antigen stimulation, possibly due to circulating
memory cells in the peripheral blood of the immunized
birds. These findings may indicate that the Salmonella
Gallinarum ghost vaccine could be as efficient as the
other vaccines for activation of the lymphocytes.
In addition, we investigated dynamic changes in CD4+
and CD8+ T-lymphocyte populations in the immunized
and non-immunized chickens. Analysis of the T cell
populations in the respective vaccination groups
revealed significant changes in T cell population profiles
in all vaccinated groups compared to the non-
immunized control group A (Figure 4). Our data show
that vaccination with Salmonella Gallinarum ghosts
induced a relative increase in the percentages of CD3
+CD4+ and CD3+CD8+ T lymphocytes in the chickens.
CD4+ T cells represent a major T cell population and are
well known as T helper cells mainly associated with the
Th1 and Th2 immune responses via the production of
Th1 cytokines and increased antibody secretion, respect-
ively [45]. CD8+ T cells, also known as cytotoxic T cells,
play an important role in immune protection against
intracellular bacterial parasites such as Listeria monocy-
togenes, Mycobacterium tuberculosis, and Salmonella
enterica [45-47]. Thus, enhanced populations of these T
cells in the immunized host are involved in protecting
against intracellular pathogens. Increased CD4+ and
CD8+ T cell populations in the chickens immunized with
a live Salmonella Gallinarum mutant have been shown
to correlate with protection against FT [36]. The data
presented in this paper demonstrate that all immunized
groups had CD4+ and CD8+ T cell populations and thepercentages were significantly higher than those of the
control group (Figure 4), indicating a strong cell-
mediated immune response. The immune response
observed in our study was similar to that induced in
BG-vaccinated animals [14,37], and involved the gener-
ation of CD4+ and CD8+ T cells. Taken together, our
data demonstrate that vaccination with the Salmonella
Gallinarum ghosts induced a significant cellular immune
response characterized by effective antigen-specific
lymphocyte activation with enhanced production of T
helper (CD4+) and cytotoxic (CD8+) T lymphocytes.
However, it would be interesting to know whether there
was an increase in the actual lymphocyte populations in
the immunized groups in response to immunization and
the relative increase in the percentages of the CD4+ and
CD8+ T cells should be recalculated back to the real
numbers to know if the changes were due to increases
in these lymphocyte subpopulations.
In conclusion, the present study demonstrates that the
vaccination of chickens with the Salmonella Gallinarum
ghosts is a safe approach for preventing FT without in-
ducing adverse clinical symptoms. Immunization with
the Salmonella Gallinarum ghost not only led to signifi-
cant immune responses but also provided efficient pro-
tection against experimentally-induced systemic FT.
Taken together, these findings suggest that the newly
constructed Salmonella Gallinarum ghost appears to be
a promising vaccine candidate and can be used as a safe
and highly immunogenic vaccine against FT although
further safety and efficacy trials on the field are needed.
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